MS patients have increased risks of developing other autoimmune diseases, necessitating careful treatment planning to balance efficacy and risk. Dimethyl fumarate, anti-CD20 antibodies, and ozanimod ...

Cladribine, a nucleotide (deoxyadenosine) analogue, inhibits deoxyribonucleic acid (DNA) synthesis in proliferating lymphocytes, causing DNA damage and depleting their number by apoptosis and ...

Brenig has launched an early Phase 1 trial to evaluate BT-409, its experimental small molecule therapy, in healthy volunteers ...

Video content above is prompted by the following: The multiple sclerosis (MS) treatment landscape has dramatically evolved from just 4 interferon-based agents in 2010 to over 22 disease-modifying ...

Two key symptoms that can arise soon after a diagnosis of multiple sclerosis (MS) could predict how swiftly the illness will progress and suggest best treatment options, new research shows. Photo by ...

Modern disease-modifying drugs (DMTs) have revolutionized the treatment of relapsing-remitting multiple sclerosis (MS). However, their use during pregnancy has long been concerning. A study published ...

Taking oral caffeine supplements may significantly reduce fatigue and improve quality of life and mood in people with MS, trial results show.

Considering the CLARITY Phase III study results, cladribine tablets may offer several improvements over existing MS drugs including a simple, short-course annual dosing regimen of either 2 or 4 weeks ...

Many women develop multiple sclerosis (MS) during their reproductive years. Since MS treatment can affect pregnancy, understanding your birth control options can make family planning easier. Research ...